Company Search:
Advanced Search
Sponsored Links
Regeneus Ltd Company Snapshot
Regeneus Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other companies in this sector in AUSTRALIA : Acrux Ltd (2021 sales of 4.79 million Australian Dollars [US$3.47 million] of which 100% was Developing and Commercialising products ), Adalta Ltd (3.99 million Australian Dollars [US$2.89 million] of which 100% was Pharmaceutical), and Noxopharm Ltd (5.75 million Australian Dollars [US$4.17 million] of which 100% was Clinical development).

Sales Analysis. Sales increased substantially in 2021: Regeneus Ltd reported sales of A$7.07 million (US$5.12 million) for the fiscal year ending June of 2021. This represents an increase of 324.9% versus 2020, when the company's sales were A$1.66 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regeneus Ltd
  Stock Performance Chart for Regeneus Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): .08
(Figures in Australian Dollars)
1 Week 4.1%   13 Weeks -2.6%  
4 Weeks 1.3%   52 Weeks -52.5%  
Regeneus Ltd Key Data:
  Ticker: RGS Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2021 Sales 7,067,026
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 22,821,613
  Fiscal Yr Ends: June Shares Outstanding: 300,284,381
  Share Type: Ordinary Closely Held Shares: 128,863,308
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.